Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 27, 2023
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
[ Fri, Jan 27th 2023
] - WOPRAI
Roanna Ruiz Maintained (VIR) at Buy with Decreased Target to $43 on, Jan 27th, 2023
Roanna Ruiz of SVB Leerink, Maintained "Vir Biotechnology, Inc." (VIR) at Buy with Decreased Target from $45 to $43 on, Jan 27th, 2023.
Roanna has made no other calls on VIR in the last 4 months.
There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 0 agree with Roanna's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Roanna
- Andrew Galler of "Morgan Stanley" Maintained at Sell with Increased Target to $18 on, Friday, November 4th, 2022
- Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $32 on, Friday, November 4th, 2022
